|
I.A. Bondar’, V.V. Klimontov, A.I. Simakova
Inflammatory cytokines in pathogenesis, diagnosis and treatment of diabetic nephropathy
|
№6 / 2010
|
|
M.L. Nanchikeeva, L.V. Kozlovskaya
Nephroprotecive and cardioprotective effects of angiotensin-converting enzyme inhibitor in patients with hypertensive nephropathy
|
№6 / 2010
|
|
A.A. Galushkin, M.M. Batiushin, V.P. Terent’ev, Yu.Yu. Gorbliasky, V.N. Stepkova, N.N. Volikov
Hypertensive nephropathy evolution in patients with metabolic syndrome
|
№6 / 2010
|
|
J.S. Milovanov, L.J. Milovanova, L.V. Kozlovskaya
Anaemia in chronic kidney disease: pathogenesis, prognostic sighnificance, treatment
|
№6 / 2010
|
|
Resolution of working group “Organization of nephrological service in Russia” meeting on VII Congress of Russian Scientific Society of Nephrology
|
№6 / 2010
|
|
Address of chief out-of-state nephrologist of Ministry of Healthcare and Social Development of Russian Federation professor E.M. Shilov
|
№6 / 2010
|
|
*
Bowman capsule
|
№5 / 2010
|
|
V.V. Fomin, A.A. Pulin, V.V. Rameev, V.P. Sedov, A.D. Meshkov, S.V. Roschupkina, V.V. Panasiuk, L.V. Kozlovskaya, N.A. Moukhin
Fabry disease with proteinuric nephropathy and hypertrophic cardiomyopathy, misinterpreted as chronic glomerulonephritis in Schonlein-Henoch purpura
|
№5 / 2010
|
|
V.V. Fomin, V.V. Panasiuk
Frequent pitfalls in antihypertensive therapy
|
№5 / 2010
|
|
I.A. Bondar, V.V. Klimontov
Intracellular signalling pathways in diabetic nephropathy: new targets for nephroprotection
|
№5 / 2010
|
|
M.L. Maximov
Angiotensin II receptor blocker valsartan and angiotensin-converting enzyme inhibitor enalapril in hypertensive patients with renal transpalant nephropathy
|
№5 / 2010
|
|
L.V. Podorolskaya, E.L. Tchumakova, L.V. Lobanova, L.A. Alexeeva
Fibrinolytic activity of the urine in patients with arterial hypertension with different efficacy of antihypertensive treatment
|
№5 / 2010
|
Русский
